HSBC Holdings plc Analysts Give Roche Holding Ltd. (ROG) a CHF 215 Price Target

Roche Holding Ltd. (VTX:ROG) received a CHF 215 price target from investment analysts at HSBC Holdings plc in a research report issued to clients and investors on Tuesday, July 11th. The firm presently has a “sell” rating on the healthcare company’s stock.

Other research analysts have also issued reports about the stock. Goldman Sachs Group, Inc. (The) set a CHF 335 price objective on shares of Roche Holding and gave the stock a “buy” rating in a report on Saturday, May 20th. Jefferies Group LLC set a CHF 305 price objective on shares of Roche Holding and gave the stock a “buy” rating in a report on Saturday, May 20th. J P Morgan Chase & Co reissued a “buy” rating on shares of Roche Holding in a report on Wednesday, June 7th. UBS AG set a CHF 260 price objective on shares of Roche Holding and gave the stock a “neutral” rating in a report on Thursday, July 6th. Finally, Deutsche Bank AG set a CHF 260 price target on shares of Roche Holding and gave the stock a “neutral” rating in a research report on Friday, July 7th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and seven have given a buy rating to the stock. The stock has an average rating of “Hold” and an average target price of CHF 271.08.

Roche Holding (VTX ROG) traded down 0.08% during midday trading on Tuesday, hitting CHK 247.20. 1,045,421 shares of the stock traded hands. The company has a market cap of CHK 210.93 billion and a PE ratio of 21.95. The company’s 50-day moving average is CHK 246.12 and its 200-day moving average is CHK 251.76. Roche Holding has a one year low of CHK 218.30 and a one year high of CHK 273.00.

WARNING: This report was first posted by Markets Daily and is the property of of Markets Daily. If you are reading this report on another website, it was stolen and reposted in violation of United States and international copyright & trademark law. The original version of this report can be viewed at https://www.themarketsdaily.com/2017/08/08/hsbc-holdings-plc-analysts-give-roche-holding-ltd-rog-a-chf-215-price-target-updated-updated-updated.html.

About Roche Holding

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Analyst Recommendations for Roche Holding (VTX:ROG)

Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply